Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |